Eurofins BioPharma Services Newsletter 23 - 2019
Eurofins presenta la nuova edizione della newsletter BioPharma NEWS.
Articoli contenuti:
- Shedding light on phenotypic drug discovery to advance oncology efforts
- Improving cancer treatment with molecular diagnostics
- Eurofins provides one-stop solution for biocidal products authorisation
- CRISPR/Cas - the system that revolutionises gene editing
- Self Emulsifying Drug Delivery Systems as a formulation strategy to improve oral bioavailability
- Eurofins Lancaster Labs’ newly opened largest building expansion is Lean and Green
> Scarica la newsletter in formato PDF
Cordiali saluti.
Il comitato editoriale del gruppo Eurofins.